Font Size: a A A
Keyword [Portosystemic shunt]
Result: 41 - 60 | Page: 3 of 6
41. Transjugular Intrahepatic Portosystemic Shunt (TIPS) For Refractory Ascites In Cirrhotic Patients:Long-term Clinical Outcome And Prognostic Indicators
42. Comparison Of TIPS For Variceal Bleeding In Idiopathic Non-cirrhotic Vs. Cirrhoticportal Hypertension: A Case-control Study
43. The Impact Of TIPS Combined With Large Spontaneous Portosystemic Shunt Embolization On Hepatic Encephalopathy, Variceal Bleeding And Survival
44. Transjugular Intrahepatic Portosystemic Shunt For Portal Vein Thrombosis With Portal Hypertensive Complication
45. Transjugular Intrahepatic Portosystemic Shunt Compared With Endoscopic Treatment Plus ?-blocker For Prevention Of Variceal Rebleeding: A Meta-analysis
46. The Comparison Of Clinical Effect Of Simulative Viatorr With Single Covered Stent Used In TIPS Among Patients With Portal Hypertension Complicated With Upper Gastrointestinal Hemorrhage
47. Clinical Application Of Viatorr Covered Stent In Transjugular Intrahepatic Portosystemic Shunt
48. The Impact Of TIPS Joint PSE On Hemodynamic And Immune Function In Patients With Portal Hypertension And Hypersplenism
49. Application Value Of Ultrasound Assessment In Postoperative Of Trasjugular Intrahepatic Portosystemic Shunt
50. EVL Versus TIPS In Cirrhosis Patients With Portal Vein Thrombosis And Esophageal Varices
51. Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Therapy In The Secondary Prophylaxis Of Variceal Rebleeding In Hepatocirrhosis Patients:a Meta-analysis
52. Current Diagnosis And Management Of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy
53. Study Between The TIPS Stents Release Parameters And Shunt Dysfunction
54. A Preliminary Study Of The Assessment Of 320-Slice CT Angiography Simulation Puncture Path Before Intrahepatic Portosystemic Shunt
55. The Treatment Of TIPS For Cirrhotic Patients With RA:Risk Stratification And Survival Prediction
56. Clinical Diagnosis And Treatment Of Hepatic Sinus Obstruction Syndrome
57. Clinical Analysis Of Liver Cirrhosis With Portal Vein Thrombosis And Analysis Of Coagulation Related Indexes
58. Transjugular Intrahepatic Portosystemic Shunt Plus Embolotherapy Prevents Rebleeding In Cirrhotic Patients With Cavernous Transformation Of The Portal Vein
59. Transjugular Intrahepatic Portosystemic Shunt For The Prevention Of Recurrent Esophageal Variceal Bleeding In Patients With Cavernous Transformation Of Portal Vein
60. Establishment And Validation Of Clinical Prediction Models In Patients With Early Hepatic Encephalopathy Undergoing Transjugular Intrahepatic Portosystemic Shunt
  <<First  <Prev  Next>  Last>>  Jump to